A. E. Dorofeyev

Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population

Alexander Koliada, Ganna Syzenko, Vladislav Moseiko et al. · BMC Microbiology · 2017 · 1K citations · Full text

Life Sciences, Microbiology, Metagenomics +15

Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study

Byong Duk Ye, Marina Pesegova, Olga Alexeeva et al. · The Lancet · 2019 · 209 citations · Full text

Medicine, Clinical Sciences, Immunology +11

814 - Phase Iii Randomized Controlled Trial to Compare Biosimilar Infliximab (CT-P13) with Innovator Infliximab in Patients with Active Crohn's Disease: 1-Year Maintenance and Switching Results

Byong Duk Ye, Young Ho Kim, Marina Pesegova et al. · Gastroenterology · 2018 · 21 citations

Pharmacy, Clinical Sciences, Pharmacotherapy +11

DOP061 Phase III randomised, double-blind, controlled trial to compare biosimilar infliximab (CT-P13) with innovator infliximab in patients with active Crohn's disease: early efficacy and safety results

Yong‐Hwan Kim, B.D. Ye, Marina Pesegova et al. · Journal of Crohn s and Colitis · 2017 · 19 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial

Wolfgang Kruis, Britta Siegmund, Konrad Leśniakowski et al. · Journal of Crohn s and Colitis · 2022 · 14 citations · Full text

Pharmacy, Pharmacotherapy, Gastroenterology +16